apixaban
Eliquis (apixaban) is a direct oral anticoagulant (factor Xa inhibitor) used to prevent strokes in atrial fibrillation and to treat and prevent blood clots (DVT and pulmonary embolism).
Medically reviewed by MedCentralHub Medical Review Board, Licensed Pharmacists & Physicians ·
Quick Reference

Eliquis (apixaban) is a direct oral anticoagulant (factor Xa inhibitor) used to prevent strokes in atrial fibrillation and to treat and prevent blood clots (DVT and pulmonary embolism).
Eliquis (apixaban) belongs to the Anticoagulants class of medications. It was first approved by the FDA in 2012. This medication requires a prescription from a licensed healthcare provider.
This is a summary only. Always read the full prescribing information and consult your healthcare provider for personalized medical advice.
Eliquis is prescribed for the following conditions. Some uses are FDA-approved indications; others may be evidence-based off-label uses. Consult your healthcare provider for personalized guidance.

The following are general dosing guidelines only. Your actual dose should be determined by your healthcare provider based on your condition, renal/hepatic function, and other medications.
5 mg twice daily for atrial fibrillation (2.5 mg twice daily if any two of: age ≥80, weight ≤60 kg, creatinine ≥1.5 mg/dL). For DVT/PE: 10 mg twice daily for 7 days, then 5 mg twice daily.
Use with caution in significant renal impairment; dose reduction may apply.
Available Forms
Available Strengths


Always inform your healthcare provider and pharmacist about ALL medications you take, including prescriptions, OTC medicines, vitamins, and supplements.
Strong dual CYP3A4 + P-gp inhibitors (ketoconazole, ritonavir, itraconazole, clarithromycin)
Combination raises apixaban AUC by up to 2-fold, significantly increasing bleeding risk.
Management: Reduce apixaban to 2.5 mg twice daily if patient is on standard dose; avoid if on 2.5 mg.
Strong dual CYP3A4 + P-gp inducers (rifampin, carbamazepine, phenytoin, St. John's Wort)
Reduce apixaban exposure by ~54%, risking thromboembolic events.
Management: Avoid concurrent use. Consider parenteral anticoagulation if urgent.
Aspirin and NSAIDs
Antiplatelet/anticoagulant combination increases major bleeding risk substantially.
Management: Use lowest possible aspirin dose; avoid NSAIDs. Use gastric protection if combination essential.
Other anticoagulants / antiplatelets (warfarin, clopidogrel, heparin)
Additive anticoagulation significantly raises bleeding risk.
Management: Avoid combinations unless carefully supervised (e.g., ACS bridge therapy).
Moderate CYP3A4/P-gp inhibitors (fluconazole, diltiazem, amiodarone)
May increase apixaban levels by ~30–50%.
Management: Use with caution; no dose adjustment required but monitor for bleeding signs.
P-gp + weak CYP3A4 inducers (nafcillin, apalutamide)
May reduce apixaban exposure moderately.
Management: Monitor for loss of anticoagulation efficacy; consider dose adjustment if needed.
Increased risk of stroke if discontinued prematurely in atrial fibrillation.
Spinal/epidural hematoma risk with neuraxial anesthesia.
Increased bleeding risk; assess before procedures.
Not recommended in patients with prosthetic heart valves.

Apixaban directly and reversibly inhibits factor Xa, a key enzyme in the coagulation cascade, reducing thrombin generation and clot formation without requiring antithrombin.
Absorption
Bioavailability ~50%; peak in 3–4 hours
Half-Life
Approximately 12 hours
Metabolism
CYP3A4 (partial); substrate of P-gp
Excretion
Renal (~27%) and fecal

Many medications pass into breast milk in varying amounts. Before using Eliquiswhile breastfeeding, discuss the benefits and risks with your healthcare provider or pharmacist — they can weigh your dose, your infant's age, and available lactation safety data to find the safest option for you and your baby.

Store at room temperature, 20–25°C (68–77°F).
Yes. Andexanet alfa (Andexxa) is FDA-approved to reverse apixaban in life-threatening bleeding; prothrombin complex concentrates are also used.
Both are factor Xa inhibitors. Eliquis (apixaban) is dosed twice daily and is often associated with a somewhat lower bleeding risk in studies; Xarelto (rivaroxaban) is usually once daily with food. Your clinician chooses based on your situation.
Moderate alcohol may be acceptable, but heavy or binge drinking raises bleeding and fall risk. Discuss your personal limit with your doctor.
Anticoagulants alternatives
Compare all Anticoagulants medications — uses, side effects, and cost differences
Eliquis dosage guide
Adult, pediatric, renal, and hepatic dosing for Eliquis
Eliquis side effects
Complete adverse effect profile including common, serious, and rare reactions
Eliquis drug interactions
Full interaction list with severity ratings for Eliquis
Atrial fibrillation treatment options
Medications, lifestyle changes, and clinical guidance for Atrial fibrillation
Deep vein thrombosis treatment options
Medications, lifestyle changes, and clinical guidance for Deep vein thrombosis
Pulmonary embolism treatment options
Medications, lifestyle changes, and clinical guidance for Pulmonary embolism
Eliquis and Strong dual CYP3A4 + P-gp inhibitors (ketoconazole, ritonavir, itraconazole, clarithromycin) interaction
Check the clinical significance of combining Eliquis with Strong dual CYP3A4 + P-gp inhibitors (ketoconazole, ritonavir, itraconazole, clarithromycin)
Eliquis and Strong dual CYP3A4 + P-gp inducers (rifampin, carbamazepine, phenytoin, St. John's Wort) interaction
Check the clinical significance of combining Eliquis with Strong dual CYP3A4 + P-gp inducers (rifampin, carbamazepine, phenytoin, St. John's Wort)
Eliquis (apixaban) is one of the most widely prescribed blood thinners in the world, used to lower the risk of stroke and dangerous blood clots. As a direct oral anticoagulant (DOAC), it offers a major practical advantage over older drugs like warfarin: predictable dosing with no routine INR blood-test monitoring and far fewer food interactions. It is taken as a small tablet twice daily and works within hours of the first dose.
Eliquis belongs to the Anticoagulants class of medications. Apixaban directly and reversibly inhibits factor Xa, a key enzyme in the coagulation cascade, reducing thrombin generation and clot formation without requiring antithrombin. Understanding how Eliquis works helps explain both its therapeutic benefits and its characteristic side-effect profile, and it is the reason clinicians monitor specific parameters during treatment.
## What Eliquis is used for
Eliquis is prescribed for Stroke prevention in non-valvular atrial fibrillation, Treatment of deep vein thrombosis (DVT), Treatment of pulmonary embolism (PE), Prevention of DVT after hip or knee replacement surgery. In atrial fibrillation, an irregular heartbeat lets blood pool and clot in the heart, and those clots can travel to the brain and cause a stroke — Eliquis sharply reduces that risk. It is also a first-line choice for treating an existing deep vein thrombosis or pulmonary embolism and for preventing recurrence, as well as for clot prevention after major orthopedic surgery. Your prescriber decides whether Eliquis is appropriate based on your diagnosis, other medical conditions, current medications, and treatment goals. Eliquis is available by prescription only and has been FDA-authorized since 2012.
## Dosage and administration
Typical adult dosing: 5 mg twice daily for atrial fibrillation (2.5 mg twice daily if any two of: age ≥80, weight ≤60 kg, creatinine ≥1.5 mg/dL). For DVT/PE: 10 mg twice daily for 7 days, then 5 mg twice daily.
The standard atrial-fibrillation dose is 5 mg twice daily, reduced to 2.5 mg twice daily for patients who meet specific age, weight, or kidney criteria. For an acute clot, a higher 10 mg twice-daily "lead-in" dose is used for the first 7 days. Because the drug clears in about 12 hours, missing doses meaningfully lowers protection, so consistency matters. Never change your dose or stop Eliquis without speaking to your prescriber. Dose adjustments may be needed for older adults, low body weight, kidney or liver impairment, or when Eliquis is combined with interacting drugs. Available forms include Oral tablet, in strengths of 2.5 mg, 5 mg.
## Side effects
Like all medicines, Eliquis can cause side effects, though many people tolerate it well. Common side effects include Bruising, Minor bleeding, Nausea, Anemia. These are often mild and tend to settle as your body adjusts. Serious side effects that warrant prompt medical attention include Major bleeding, Gastrointestinal hemorrhage, Intracranial bleeding, Spinal/epidural hematoma. The defining risk of any anticoagulant is bleeding, ranging from easy bruising and nosebleeds to rare but serious gastrointestinal or brain hemorrhage. Importantly, a reversal agent (andexanet alfa) exists for life-threatening bleeds, which is reassuring in emergencies. Tell every doctor and dentist you see that you take Eliquis, especially before any procedure. Seek emergency care for signs of a severe allergic reaction — hives, swelling of the face or throat, or difficulty breathing.
## Managing common side effects
Many of the common effects of Eliquis can be eased with simple self-care while your body adjusts:
If any side effect is severe, does not improve, or interferes with daily life, contact your healthcare provider rather than stopping Eliquis on your own.
## Warnings and precautions
Before starting Eliquis, tell your healthcare provider about all your medical conditions and every medication, supplement, and herbal product you take. Key precautions: Increased risk of stroke if discontinued prematurely in atrial fibrillation; Spinal/epidural hematoma risk with neuraxial anesthesia; Increased bleeding risk; assess before procedures; Not recommended in patients with prosthetic heart valves. Eliquis is not recommended for people with mechanical (prosthetic) heart valves or moderate-to-severe mitral stenosis, where warfarin remains the standard. It is also avoided in active major bleeding and used cautiously with severe liver disease. During pregnancy, Eliquis carries a labeled status of "Not recommended"; discuss the risks and benefits with your clinician if you are pregnant, planning pregnancy, or breastfeeding.
## Drug interactions
Eliquis can interact with NSAIDs and aspirin (major) — Increased bleeding risk; Strong CYP3A4/P-gp inhibitors (e.g., ketoconazole, ritonavir) (major) — Raise apixaban levels and bleeding risk; Other anticoagulants/antiplatelets (major) — Additive bleeding risk. Combining Eliquis with NSAIDs (ibuprofen, naproxen), aspirin, or other blood thinners raises bleeding risk, while strong CYP3A4/P-gp inhibitors or inducers can push apixaban levels too high or too low. Because interactions can reduce effectiveness or raise the risk of harm, keep an up-to-date medication list and have your pharmacist run an interaction check whenever a new drug is added.
## Cost, coverage, and savings
Out-of-pocket cost for Eliquis varies widely depending on insurance, pharmacy, and whether a generic is available. Eliquis is brand-only in much of the world and can be expensive without coverage, though a U.S. generic is expected to broaden access. Bristol Myers Squibb/Pfizer offer a manufacturer savings program for eligible commercially-insured patients, and a patient-assistance program exists for those who qualify. Patients commonly look for a eliquis copay card, manufacturer savings card, or patient assistance program to lower cost; the manufacturer's official site and your pharmacist are the most reliable sources for current offers. Comparing cash prices across pharmacies and discount programs can also produce meaningful savings.
## How Eliquis compares to alternatives
Compared with warfarin, Eliquis needs no INR monitoring and has fewer dietary restrictions. Versus its closest rival Xarelto (rivaroxaban), Eliquis is dosed twice daily (Xarelto is once daily with food) and has shown a somewhat lower major-bleeding rate in several analyses, though both are highly effective. The "best" option is individual: it depends on your condition, response, tolerability, other medicines, insurance coverage, and dosing convenience. Discuss alternatives with your prescriber rather than switching on your own, and never stop a prescribed medicine abruptly unless told to.
## Monitoring and lifestyle
Treatment with Eliquis works best alongside follow-up and healthy habits. No routine blood monitoring is required, but your clinician will periodically check kidney function and hemoglobin, and reassess bleeding risk — especially in older adults and around any surgery or dental work. A balanced diet, regular physical activity appropriate to your health, adequate sleep, limited alcohol, and not smoking all support better outcomes and may improve how well Eliquis works. Keep scheduled appointments and laboratory tests so your clinician can confirm the medicine is helping and catch any problems early.
## What to expect from treatment
Knowing the timeline helps set realistic expectations. Eliquis is typically absorbed with bioavailability ~50%; peak in 3–4 hours, and has an elimination half-life of about 12 hours, which shapes how often you dose it and how quickly it leaves your system if stopped. Some people notice effects early, while for others the full benefit of Eliquis builds over weeks of consistent use. Success is measured against your personal treatment goals — whether that is better disease control, fewer symptoms, or reduced long-term risk — so keep your follow-up appointments so progress can be confirmed objectively rather than by guesswork.
## Before you start Eliquis
A thorough pre-treatment review helps Eliquis work safely. Tell your prescriber about heart, liver, or kidney problems, any history of allergic reactions, and whether you are pregnant or breastfeeding. Bring a complete list of prescription drugs, over-the-counter products, vitamins, and herbal supplements so interactions can be screened. Your clinician may order baseline tests and will set clear goals and a follow-up plan before you begin Eliquis. Ask what results to expect, how long until the medicine takes effect, and which symptoms should prompt a call.
## Missed dose and overdose
If you miss a dose of Eliquis, take it as soon as you remember unless it is almost time for the next dose — in that case skip the missed dose and continue your regular schedule. Do not double up to make up for a missed dose. If you suspect an overdose or someone has taken too much, contact your local poison control center or emergency services immediately. Using a pill organizer, phone reminder, or refill-reminder service helps maintain consistent dosing, which is important for Eliquis to work properly.
## Use in specific populations
Pregnancy and breastfeeding: Eliquis carries a labeled status of "Not recommended." Tell your clinician if you are pregnant, may become pregnant, or are breastfeeding so the safest plan can be chosen. Older adults may be more sensitive to side effects and sometimes need lower doses or closer monitoring. Kidney or liver impairment can change how Eliquis is handled by the body and may require dose adjustment. Children and adolescents should use Eliquis only when specifically indicated and supervised by an appropriate specialist.
## When to contact your doctor
Contact your healthcare provider if your symptoms do not improve, if side effects are persistent or troubling, or if you have new symptoms after starting Eliquis. Call emergency services for chest pain, trouble breathing, fainting, severe bleeding, sudden severe headache, or signs of a serious allergic reaction. Do not stop Eliquis on your own — abrupt discontinuation of some medicines can cause rebound effects or loss of disease control.
## Storage and handling
Store at room temperature, 20–25°C (68–77°F). Keep Eliquis in its original container, out of the reach of children and pets, and away from excess heat and moisture. Check the expiration date before use and do not use a product that looks discolored or damaged. Dispose of unused or expired medicine safely through a pharmacy take-back program rather than flushing it, unless the label specifically instructs otherwise.
## Clinical evidence and effectiveness
Approval was based on large randomized trials including ARISTOTLE (atrial fibrillation), which showed apixaban reduced stroke and caused less major bleeding than warfarin, and the AMPLIFY program for treating venous thromboembolism. The degree of benefit varies from person to person, and real-world results depend on consistent use, adherence to the rest of your treatment plan, and individual factors such as other conditions and medications. Ongoing post-marketing surveillance continues to refine what is known about Eliquis's long-term safety and effectiveness, and clinical guidelines are updated as new evidence emerges. Your prescriber can explain what the evidence means for your specific situation and what improvement is realistic to expect.
## Tips for getting the most from Eliquis
Consistency is the single most important factor: take Eliquis at the same time and in the same way each day, and refill before you run out to avoid interruptions. Keep a simple symptom-and-side-effect diary for the first weeks so you and your clinician can judge how well it is working. Store the medicine correctly, never share it with others, and bring it (or a current list) to every medical appointment. If cost or access is a barrier, raise it early — pharmacists can often suggest generics, manufacturer programs, or therapeutic alternatives that keep you on track.
## Frequently asked questions about Eliquis
Yes. Andexanet alfa (Andexxa) is FDA-approved to reverse apixaban in life-threatening bleeding; prothrombin complex concentrates are also used.
Both are factor Xa inhibitors. Eliquis (apixaban) is dosed twice daily and is often associated with a somewhat lower bleeding risk in studies; Xarelto (rivaroxaban) is usually once daily with food. Your clinician chooses based on your situation.
Moderate alcohol may be acceptable, but heavy or binge drinking raises bleeding and fall risk. Discuss your personal limit with your doctor.
## Key takeaways
To summarize the most important points about Eliquis (apixaban):
## Medical disclaimer
This article about Eliquis (apixaban) is for general education and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow the guidance of your physician or pharmacist and the instructions on your prescription label. Information may change as new evidence emerges.
Last reviewed by MedCentralHub Medical Review Board · MedCentralHub Editorial Policy
Medical Disclaimer
The information on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult your doctor, pharmacist, or qualified healthcare provider before starting, stopping, or changing any medication.